<DOC>
	<DOCNO>NCT02906579</DOCNO>
	<brief_summary>To evaluate impact escalate dos IW-1973 endothelial function [ use EndoPAT measure fingertip small vessel pulse volume ] , blood pressure ( BP ) , heart rate .</brief_summary>
	<brief_title>A Phase 2 Trial IW-1973 , A Stimulator Soluble Guanylate Cyclase ( sGC ) , Patients With Stable Type 2 Diabetes Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patient ambulatory male female Patient 's body mass index score &gt; 20 &lt; 40 kg/m2 Screening Visit Women childbearing potential must negative pregnancy test time checkin must agree use doublebarrier contraception throughout duration study Patient 's health stable clinically significant finding physical examination Patient type 2 ( ie adult onset ) diabetes mellitus diagnose physician nurse practitioner &gt; 6 month Screening Visit , entry HbA1c mandate prompt intervention improve control Patient hypertension diagnose physician nurse pratictioner &gt; 6 month Screening Visit BP within protocol 's acceptable range Patients must stable regimen glycemic control , stable regimen hypertension control include angiotensin convert enzyme inhibitor ( ACEi ) angiotensin receptor blocker ( ARB ) Patient abnormal endothelial function measure EndoPAT Other inclusion criterion per protocol Patient clinically significant active unstable medical condition , opinion Investigator , would preclude trial participation Patient medication ( ) coadministered soluble guanylate cyclase ( sGC ) stimulator , could increase risk hypotension Patient evidence severe active endorgan damage attributable diabetes Patient severe renal insufficiency , undergone renal transplantation , plan renal transplantation Other exclusion criterion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>